Large-scale testing (Phase 3)Ended earlyNCT06514742
What this trial is testing
Aticaprant 10 mg as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy and Long-term Extension Treatment With Aticaprant
Who this might be right for
Depressive Disorder, MajorAnhedonia
Janssen Research & Development, LLC 101